RxDoctor Payments Data

Clay Spitler

Orthopaedic Trauma · Birmingham, ALNPI 1356518617

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $60,237 of the $84,844 with a category attached, or 71.0%. Medical Device Business Services, Inc. accounts for 71.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $25,064 and has fallen 82.8% since, to $4,301 in 2025.

$84,844in general payments, 2019–2025

Across 241 payments — averaging $352.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$61K
  • Synthes GmbH$11K
  • Osteocentric Technologies, Inc.$4K
  • Smith+Nephew$3K
  • Johnson & Johnson$3K
  • KCI USA, Inc.$1K
  • plus $998 from 11 others
$167,799in research payments, 2019–2025

Across 44 payments — averaging $3813.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Next Science LLC$92K
  • Stryker$44K
  • Medical Device Business Services, Inc.$32K

What the payments were for

  • Consulting fees$60,23771%
  • Speaking & faculty fees$8,60010%
  • Travel & lodging$9,29311%
  • Food & beverage$6,7138%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in Alabamato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$103,791
Medicare patients
136
Services billed
286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin33$320
Methocarbamol23$149
Oxycodone Hcl28$121

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →